These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34584239)

  • 21. B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma - a case report.
    Baermann BN; Jäger P; Kobbe G
    Ann Hematol; 2022 Nov; 101(11):2541-2542. PubMed ID: 35918460
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
    Redjoul R; Le Bouter A; Parinet V; Fourati S; Maury S
    Lancet Haematol; 2021 Oct; 8(10):e681-e683. PubMed ID: 34487683
    [No Abstract]   [Full Text] [Related]  

  • 23. Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn.
    Hill JA
    JAMA Netw Open; 2021 Sep; 4(9):e2127454. PubMed ID: 34519771
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT.
    Leclerc M; Redjoul R; Le Bouter A; Beckerich F; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Roy L; Cabanne L; Nait-Sidenas Y; Harfouch E; Gautier E; Fourati S; Maury S
    Lancet Haematol; 2022 May; 9(5):e318-e321. PubMed ID: 35378072
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients.
    Malek AE; Adachi JA; Mulanovich VE; Sassine J; Raad II; McConn K; Seiler GT; Dhal U; Khawaja F; Chemaly RF
    Transpl Infect Dis; 2021 Aug; 23(4):e13606. PubMed ID: 33755273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.
    Asti AL; Lilleri D; Gregorini M; Zelini P; Pattonieri EF; Sepe V; Libetta C; Islami T; Baldanti F; Rampino T
    New Microbiol; 2021 Jul; 44(3):184-186. PubMed ID: 34783351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
    Anurathapan U; Apiwattanakul N; Pakakasama S; Pongphitcha P; Thitithanyanont A; Pasomsub E; Hongeng S
    Bone Marrow Transplant; 2020 Dec; 55(12):2359-2360. PubMed ID: 32528121
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?
    Sengsayadeth S; Broglie L; Savani BN
    Br J Haematol; 2022 Feb; 196(4):809-811. PubMed ID: 34850381
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients.
    Chiarucci M; Paolasini S; Isidori A; Guiducci B; Loscocco F; Capalbo M; Visani G
    Front Oncol; 2021; 11():737300. PubMed ID: 34552880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High antibody response in relation to immunosuppressive blood levels in liver transplant recipients after SARS-CoV-2 vaccination: an observational, cohort study.
    Mulder MB; van der Eijk AA; GeurtsvanKessel CH; Erler NS; de Winter BCM; Polak WG; Metselaar HJ; den Hoed CM
    Gut; 2022 Dec; 71(12):2605-2608. PubMed ID: 35101992
    [No Abstract]   [Full Text] [Related]  

  • 33. Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection.
    Weber SC; Danne F; Kieslich M; Krauss A; Berger F; Sallmon H
    J Heart Lung Transplant; 2022 Aug; 41(8):1124-1126. PubMed ID: 35697603
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute exacerbation of graft-versus-host disease following SARS-CoV2 infection after hematopoietic stem cell transplant in two pediatric patients.
    Choe M; Martinez C; Krance R; Doherty E
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29661. PubMed ID: 35293671
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination against SARS-CoV-2 in liver transplant recipients: The game is still long and the outcome is uncertain.
    Toniutto P; Cussigh A; Cmet S; Falleti E
    Liver Int; 2022 Oct; 42(10):2341. PubMed ID: 35906808
    [No Abstract]   [Full Text] [Related]  

  • 36. No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19.
    Lázaro Del Campo P; de Paz Arias R; Ramírez López A; de la Cruz Benito B; Humala Barbier K; Sánchez Vadillo I; López de la Guía A; de Soto Álvarez T; Jiménez Yuste V; Canales Albendea M
    Transfus Apher Sci; 2020 Dec; 59(6):102921. PubMed ID: 32928663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Russo D; Polverelli N; Malagola M; Farina M; Leoni A; Bernardi S; Mammoliti S; Sacchi N; Martino M; Ciceri F;
    Bone Marrow Transplant; 2021 Sep; 56(9):2272-2275. PubMed ID: 33875810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment on "SARS-CoV-2 vaccine safety and COVID-19 risk perception in hematopoietic stem cell transplant recipients".
    Mungmunpuntipantip R; Wiwanitkit V
    Support Care Cancer; 2023 Dec; 32(1):51. PubMed ID: 38129605
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19.
    Roedl K; Heidenreich S; Pfefferle S; Jarczak D; Urbanowicz TT; Nörz D; Aepfelbacher M; Kröger N; Kluge S; Lütgehetmann M; Christopeit M; Wichmann D
    Am J Respir Crit Care Med; 2021 Jan; 203(2):242-245. PubMed ID: 33253054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.